Brilinta DaYu Study
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor
- Status
- UNKNOWN
- Phase
- PHASE4
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
- Status
- TERMINATED
- Phase
- N/A
A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS
- Status
- COMPLETED
- Phase
- PHASE4
Phase I/II Trial of Antagonism of HER in GI Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
- Status
- COMPLETED
- Phase
- PHASE4
Topical Roflumilast in Adults With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
- Status
- COMPLETED
- Phase
- PHASE2
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer
- Status
- TERMINATED
- Phase
- PHASE3
The First Jordanian PCI Registry: Events at 1 Year
- Status
- COMPLETED
- Phase
- N/A
A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
- Status
- TERMINATED
- Phase
- PHASE2
YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study
- Status
- WITHDRAWN
- Phase
- PHASE4
Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients
- Status
- COMPLETED
- Phase
- PHASE4
Vandetanib in Advanced NSCLC With RET Rearrangement
- Status
- COMPLETED
- Phase
- PHASE2
Gefitinib Usage and Outcomes in Routine Treatment
- Status
- COMPLETED
- Phase
- N/A
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1